Hhlr Advisors, Ltd.
About Hhlr Advisors, Ltd.’s 13F portfolio
Hhlr Advisors, Ltd. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Hhlr Advisors, Ltd. reported $832.1M across 35 US-listed positions (). Its largest position is LEGEND BIOTECH CORP (LEGN) at 21% of the reported book, and its ten biggest holdings make up 86% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: LEGN LEGEND BIOTECH CORP | $16.25 +0.87% | 21% | 6.0M | $172.8M |
| 2 | NASDAQ: FUTU FUTU HLDGS LTD | $83.18 −4.27% | 20% | 1.8M | $165.8M |
| 3 | NASDAQ: AVBP ARRIVENT BIOPHARMA INC | $10.90 +1.96% | 16% | 3.9M | $136.5M |
| 4 | NASDAQ: MRVL MARVELL TECHNOLOGY INC | $145.54 −2.15% | 5.8% | 163K | $48.5M |
| 5 | NYSE: VIPS VIPSHOP HLDGS LTD | $12.84 −0.23% | 5.5% | 3.5M | $46.0M |
| 6 | NASDAQ: PDD PDD HOLDINGS INC | $77.45 +0.08% | 4.6% | 500K | $38.1M |
| 7 | NYSE: BEKE KE HLDGS INC | $18.49 +0.43% | 3.9% | 2.2M | $32.2M |
| 8 | NASDAQ: CTKB CYTEK BIOSCIENCES INC | $5.92 +3.86% | 3.5% | 6.7M | $29.5M |
| 9 | NASDAQ: ALMR ALAMAR BIOSCIENCES INC | — — | 3.1% | 956K | $25.9M |
| 10 | NYSE: BABA ALIBABA GROUP HLDG LTD | $84.37 −2.63% | 2.1% | 184K | $17.7M |
| 11 | NASDAQ: ODTX ODYSSEY THERAPEUTICS INC | — — | 1.9% | 832K | $15.6M |
| 12 | NYSE: YSG YATSEN HLDG LTD | $1.98 −4.81% | 1.9% | 4.9M | $15.5M |
| 13 | NASDAQ: NBP NOVABRIDGE BIOSCIENCES | $0.90 +9.83% | 1.4% | 6.0M | $11.7M |
| 14 | NASDAQ: CTNM CONTINEUM THERAPEUTICS INC | $9.24 −3.25% | 1.3% | 669K | $11.0M |
| 15 | NASDAQ: MAZE MAZE THERAPEUTICS INC | $31.20 −5.08% | 1.3% | 366K | $10.9M |
| 16 | NASDAQ: API AGORA INC | $3.28 −8.76% | 1.0% | 2.1M | $8.4M |
| 17 | NYSE: TSM TAIWAN SEMICONDUCTOR MANUFAC | $362.62 +0.81% | 0.9% | 16K | $7.4M |
| 18 | NASDAQ: SGMT SAGIMET BIOSCIENCES INC | $10.11 +2.64% | 0.7% | 725K | $5.6M |
| 19 | NASDAQ: NTES NETEASE COM INC | $118.43 −0.99% | 0.5% | 35K | $4.5M |
| 20 | NYSE: GE GE AEROSPACE | $328.10 +0.52% | 0.5% | 10K | $3.8M |
| 21 | NASDAQ: LITE LUMENTUM HLDGS INC | $551.07 −1.59% | 0.3% | 3K | $2.8M |
| 22 | NASDAQ: NVDA NVIDIA CORPORATION | $150.96 −2.89% | 0.3% | 14K | $2.8M |
| 23 | NYSE: TUYA TUYA INC | $1.52 −5.00% | 0.3% | 1.6M | $2.8M |
| 24 | NYSE: GLW CORNING INC | $108.15 −0.31% | 0.3% | 10K | $2.6M |
| 25 | NYSE: COHR COHERENT CORP | $212.84 +0.94% | 0.3% | 6K | $2.5M |
Showing 1–25 of 35 positions on this page reported in this 13F.
- Healthcare46%
- Financial Services20%
- Consumer Cyclical12%
- Technology10%
- Real Estate3.9%
- Consumer Defensive1.9%
- Communication Services0.5%
- Industrials0.5%
- Basic Materials0.1%
- AddedFUTUFUTU HLDGS LTD+24.6%$165.8M
- AddedVIPSVIPSHOP HLDGS LTD+2683%$46.0M
- NewALMRALAMAR BIOSCIENCES INC—$25.9M
- NewODTXODYSSEY THERAPEUTICS INC—$15.6M
- NewNTESNETEASE COM INC—$4.5M
- AddedLITELUMENTUM HLDGS INC+120%$2.8M
- AddedNVDANVIDIA CORPORATION+113%$2.8M
- AddedGLWCORNING INC+33.3%$2.6M
- AddedCOHRCOHERENT CORP+50.1%$2.5M
- NewTXNTEXAS INSTRS INC—$1.4M
- ReducedMRVLMARVELL TECHNOLOGY INC−4.7%$48.5M
- ReducedPDDPDD HOLDINGS INC−88.0%$38.1M
- ReducedBEKEKE HLDGS INC−47.6%$32.2M
- ReducedBABAALIBABA GROUP HLDG LTD−92.5%$17.7M
- ReducedTSMTAIWAN SEMICONDUCTOR MANUFAC−0.1%$7.4M
- ReducedBULLWEBULL CORP−79.3%$2.0M
- ReducedINTCINTEL CORP−50.6%$2.0M
- SoldBBARRICK MNG CORP−100%—
- SoldUXINUXIN LTD−100%—
- SoldRDGTRIDGETECH INC−100%—
Reading Hhlr Advisors, Ltd.’s 13F portfolio
Hhlr Advisors, Ltd.’s $832.1M 13F book is spread across 35 reported positions and is highly concentrated — its ten largest positions alone are 86% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are LEGN, FUTU, AVBP, MRVL and VIPS, led by LEGEND BIOTECH CORP (LEGN) at 21% of the portfolio. The heaviest sector exposure is Healthcare (46%), then Financial Services (20%).
What Hhlr Advisors, Ltd. changed last quarter
Between 2026-03-31 and Q2 2026, Hhlr Advisors, Ltd. was a net seller: it opened 6 new positions and added to 6 more, while trimming 7 and closing 9 outright. Against a 35-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was FUTU HLDGS LTD (FUTU), and its biggest reduction was MARVELL TECHNOLOGY INC (MRVL).
What a 13F does and doesn’t reveal
A 13F captures only Hhlr Advisors, Ltd.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Hhlr Advisors, Ltd. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Hhlr Advisors, Ltd.'s profile on this page is built directly from those filings.
How current is the 13F data on Hhlr Advisors, Ltd.'s page?
It reflects Hhlr Advisors, Ltd.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Hhlr Advisors, Ltd. files its next quarterly report, this page refreshes automatically.
Can I see Hhlr Advisors, Ltd.'s complete list of holdings?
This page highlights Hhlr Advisors, Ltd.'s largest positions rather than all 35 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Hhlr Advisors, Ltd.'s filings.
Does a 13F show everything Hhlr Advisors, Ltd. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Hhlr Advisors, Ltd.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Hhlr Advisors, Ltd. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

